Review:
Eudravigilance System In Europe
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
The EudraVigilance system in Europe is a database for the collection and management of information on suspected adverse reactions to medicines authorized in the European Economic Area (EEA). It is operated by the European Medicines Agency (EMA).
Key Features
- Centralized database for adverse reactions to medicines
- Used for monitoring drug safety in the EEA
- Facilitates communication between regulatory authorities and pharmaceutical companies
- Enhances patient safety by identifying potential risks associated with medicines
Pros
- Enhances pharmacovigilance activities in the EEA
- Improves patient safety by facilitating the early detection of potential risks
- Fosters collaboration between regulatory authorities and pharmaceutical companies
Cons
- May experience occasional technical issues or delays in data reporting
- Limited access to certain sensitive information due to privacy concerns